Canada Covid Vaccine Agreement

Pfizer and German BioNTech vaccine, which has boosted spirits and financial markets around the world with data showing it is more than 90% effective, thanks to previously unin advanced messenger RNA (mRNA) technology, such as moderna`s. “That doesn`t necessarily mean that Canada will eventually secure all these doses, because these contracts contain several candidates, some of which are unlikely to succeed, but I think it`s fair to say that we shouldn`t worry too much about Canada not having enough vaccines.” “The Medicago team is committed to being part of COVID 19`s global pandemic efforts and we look forward to the day when our vaccine is approved and provided in Canada and beyond,” said Clark. “Today`s announcement demonstrates our unwavering commitment to the development of a COVID-19 vaccine, available to everyone when it comes to the market,” said Thomas Triomphe, Executive Vice President and General Manager of Sanofi Pasteur. “To address a global health crisis of this magnitude, partnerships are needed, and we are grateful to Canada for its cooperation and to GSK for working with us to develop a safe and effective vaccine.” At the same time, the National Advisory Committee on Immunization, an external advisory group of immunization and health experts, will provide federal, provincial and territorial governments with guidance for safe and effective application of vaccines for Canadians. While other governments are investing hundreds of millions or billions in vaccine development, Canada has set up $1 billion ($761 million) to buy doses abroad. Meanwhile, Medicago, based in Quebec, worked on a tight budget on its own herbal vaccine. Canada has secured agreements to obtain up to 194 million doses of COVID-19 vaccines with the possibility of purchasing an additional $220 million. Now that Health Canada is beginning to evaluate a fourth potential vaccine candidate, Johnson and Johnson, the Prime Minister said discussions are underway with the provinces and territories on the “ethical and socially difficult” aspect of introducing vaccines to the country. “This agreement between the Canadian government and Medicago ensures that Canadians have access to another promising candidate for the COVID-19 vaccine.

Medicago is working diligently here in Canada to support the response to COVID-19 and protect the health and safety of Canadians,” said Anita Anand, Minister of Public Services and Supply. Dr. Supriya Sharma, a chief medical advisor at Health Canada, said the agency will make a decision on the Pfizer vaccine at about the same time as the United States. An FDA decision is expected on December 10. Due to the urgent need for COVID-19 vaccines, an injunction allowed them to expedite the process, including the ability to verify the data on an ongoing basis instead of having completed all attempts.

Comments are closed.